Twin Securities »

Terns Pharmaceuticals shares owned by Twin Securities

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Twin Securities from 13F filings

Historical chart of Twin Securities investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Twin Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Twin Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.1M 116k 52.72

More positions owned by Twin Securities

Electronic Arts (EA)
Warner Bros Discovery Com Ser A (WBD)
Clearwater Analytics Hldgs I Cl A (CWAN)
Hologic
Kenvue (KVUE)
Revolution Medicines (RVMD)
Arcellx Common Stock (ACLX)
Terns Pharmaceuticals (TERN)
Apellis Pharmaceuticals (APLS)
Onestream Cl A
Take-Two Interactive Software (TTWO)
Day One Biopharmaceuticals I (DAWN)
Atrium Therapeutics (RNA)
Acuren Corporation (TIC)
Manchester Utd Ord Cl A (MANU)

View all positions for Twin Securities

Top funds holding Terns Pharmaceuticals

BlackRock
Morgan Stanley
Adage Capital Partners GP
Vanguard Group
Vanguard Capital Management
venBio Select Advisor
Holocene Advisors
Balyasny Asset Management
Citadel Advisors
Millennium Management
HBK Investments
Lord, Abbett & Co
Ikarian Capital
Franklin Resources
Geode Capital Management

View all funds holding Terns Pharmaceuticals